Treponema pallidum triplet antigen

US10125177B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10125177-B2
Application numberUS-201815865594-A
CountryUS
Kind codeB2
Filing dateJan 9, 2018
Priority dateJan 13, 2011
Publication dateNov 13, 2018
Grant dateNov 13, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production methods, detection methods, and kits are also disclosed.

First claim

Opening claim text (preview).

The invention claimed is: 1. A Treponema pallidum triplet antigen comprising the amino acid sequence as shown in SEQ ID NO:10. 2. The Treponema pallidum triplet antigen of claim 1 labeled with a detectable marker. 3. The Treponema pallidum triplet antigen of claim 2 wherein the detectable marker is horseradish peroxidase. 4. A kit for detection of Treponema pallidum antibodies, the kit comprising: the Treponema pallidum triplet antigen of claim 1 ; and a second Treponema pallidum triplet antigen of claim 1 , the second Treponema pallidum triplet antigen labeled with a detectable marker. 5. The kit of claim 4 further comprising positive or negative controls. 6. The kit of claim 4 further comprising calibration samples. 7. The kit of claim 4 further comprising one or more of enzyme conjugate, substrate for enzyme conjugate, buffer solution, and washing solution. 8. A method of detecting the presence of Treponema pallidum antibodies in a sample, the method comprising: contacting the sample with a first antigen which is immobilized on a solid support and which comprises the Treponema pallidum triplet antigen of claim 1 , wherein Treponema pallidum antibodies present in the sample bind to the Treponema pallidum triplet antigen forming an antibody/antigen complex; and detecting the antibody/antigen complex, thereby detecting the presence of Treponema pallidum antibodies.

Assignees

Inventors

Classifications

  • for venereal disease, e.g. syphilis, gonorrhoea {(herpes G01N33/56994; chlamydia G01N33/56927)} · CPC title

  • containing a tag for immunodetection, or an epitope for immunisation · CPC title

  • Bacteria · CPC title

  • Fusion polypeptide · CPC title

  • from Spirochaetales (O), e.g. Treponema, Leptospira · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10125177B2 cover?
A Treponema pallidum triplet antigen construct is disclosed which includes three Treponema pallidum antigens (TP15, TP17, and TP47), as well as a ten amino acid leader sequence (tag 261) and human copper zinc superoxide dismutase (hSOD). This construct is optimized for in vitro diagnosis of syphilis infection. Plasmids containing DNA encoding the triplet antigen, host cells, production meth…
Who is the assignee on this patent?
Ortho Clinical Diagnostics Inc
What technology area does this patent fall under?
Primary CPC classification C07K14/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).